McKesson price target raised to $1,000 from $825 at Evercore ISI

Evercore ISI raised the firm’s price target on McKesson (MCK) to $1,000 from $825 and keeps an Outperform rating on the shares. The company is showing solid momentum with its North American Pharma segment, modeling around 7% core AOI growth for FY26, the analyst tells investors in a research note. While management anticipates increased second half investments, the firm said the slowdown appears conservative.